DNA Biomed Solns Working Capital to Net Assets Ratio
DNA Biomed Solns working capital to net assets ratio. DNA Biomed Solns (DNA) has a Working Capital to Net Assets ratio of 70.3% as of June 2025. Working capital of ILA69.02 Million (current assets of ILA70.47 Million minus current liabilities of ILA1.44 Million) is measured against net assets of ILA98.23 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check DNA Biomed Solns (DNA) tangible net worth to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of DNA Biomed Solns (2013–2024)
Working capital to net assets ratio of DNA Biomed Solns from 2013 to 2024. This chart shows how DNA Biomed Solns's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2013 to 2024. As of June 2025, the ratio stands at 70.3%, reflecting working capital of ILA69.02 Million against net assets of ILA98.23 Million ILA. See DNA Biomed Solns (DNA) liquidity interval to measure how many days the company can operate on defensive assets alone.
DNA Biomed Solns Working Capital to Net Assets Ratio by Year (2013–2024)
DNA Biomed Solns working capital to net assets ratio by year from 2013 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for DNA Biomed Solns from 2013 to 2024, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see DNA current and non-current assets.
| Year | WC/NA Ratio | Working Capital (ILA) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 66.3% | ILA67.30 Million | ILA101.47 Million | ILA68.43 Million | ILA1.13 Million | ▼ -17.3 pp |
| 2023 | 83.7% | ILA66.26 Million | ILA79.19 Million | ILA66.94 Million | ILA685.00K | ▲ +2.4 pp |
| 2022 | 81.3% | ILA65.14 Million | ILA80.11 Million | ILA65.93 Million | ILA789.00K | ▲ +37.8 pp |
| 2021 | 43.5% | ILA23.63 Million | ILA54.33 Million | ILA23.91 Million | ILA287.00K | ▲ +175.1 pp |
| 2020 | -131.6% | ILA-10.46 Million | ILA7.95 Million | ILA80.00K | ILA10.54 Million | ▼ -112.6 pp |
| 2019 | -19.0% | ILA-5.35 Million | ILA28.18 Million | ILA3.20 Million | ILA8.55 Million | ▲ +4.6 pp |
| 2018 | -23.6% | ILA-15.30 Million | ILA64.90 Million | ILA515.00K | ILA15.81 Million | ▼ -12.9 pp |
| 2017 | -10.7% | ILA-7.38 Million | ILA69.11 Million | ILA1.60 Million | ILA8.99 Million | ▼ -33.4 pp |
| 2016 | 22.7% | ILA-18.95 Million | ILA-83.41 Million | ILA21.93 Million | ILA40.88 Million | ▲ +105.1 pp |
| 2015 | -82.4% | ILA6.88 Million | ILA-8.35 Million | ILA11.44 Million | ILA4.56 Million | ▼ -91.7 pp |
| 2014 | 9.2% | ILA-773.00K | ILA-8.36 Million | ILA2.84 Million | ILA3.62 Million | ▼ -23.7 pp |
| 2013 | 32.9% | ILA3.78 Million | ILA11.49 Million | ILA6.64 Million | ILA2.86 Million | — |